The prescribed dosage for Genotropin (somatropin) may depend on your condition and your treatment plan. Doctors may base some dosages of the drug on body weight. Genotropin (somatropin) is a ...

A Pfizer drug for growth hormone deficiency has bounced back from an FDA rejection to finally win regulatory approval, clearing the way for the pharmaceutical giant to compete against a smaller rival ...

NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) has approved NGENLA (somatrogon-ghla), a ...

NEW YORK, April 2 (Reuters) - Pfizer Inc. on Monday said it had agreed to pay almost $35 million in fines to settle federal charges that a rival drugmaker it acquired four years ago had ...

Pfizer is on an FDA heater. With a blessing Wednesday for growth hormone deficiency (GHD) drug Ngenla (somatrogon-ghla), the New York pharma giant has racked up four approvals from the agency over the ...

Pfizer PFE along with partner OPKO Health OPK announced that the FDA has approved Ngenla (somatrogon) as a once-weekly treatment for pediatric patients aged three years and older with growth hormone ...

New, longer-acting treatment offers option to reduce the frequency of injections for children with growth hormone deficiency from daily to once-weekly Growth hormone deficiency (GHD) is a rare disease ...